bone loss

Menopause is associated with an increased risk of bone loss and fractures, according to an expert. Common symptoms include hot flushes, night sweats, irregular menstrual flow, vaginal dryness, pain during sexual intercourse, urinary incontinence, sleep disturbances, mood changes, anxiety, and depression.

Ozempic and Wegovy, GLP-1 receptor agonists, have been linked to significant muscle and bone loss in patients. Experts now outline strategies to mitigate these effects, including dietary adjustments, strength training, and monitoring calcium/vitamin D levels.

Ozempic and Wegovy, GLP-1 receptor agonists, are associated with significant muscle and bone loss in patients. Experts highlight strategies to mitigate these effects, though the side effects remain a major concern.

Scientists discovered that declining levels of the Menin protein in the hypothalamus contribute to aging-related issues like inflammation, memory loss, and bone degradation in mice. Restoring Menin or supplementing with D-serine reversed these effects, offering a potential pathway to combat age-related decline.